In the COHERE study patients were also stratified according to CD4 count, and thus is the only study providing data about the incidence of PCP in persons with CD4 counts ≤100 cells/μL and suppressed VL discontinuing prophylaxis. Here, CD4 is linked to pneumocystosis.